FrançaisMovember

Local Therapies

Movember
For more information visit
www.movember.com

In The News

Prostate Cancer Awareness Day at BC Legislative Assembly
VICTORIA, May 4, 2012- On Monday, May 7, Prostate Cancer Canada (PCC) will host their first Legislative Assembly Day to promote education and awareness of prostate cancer in British Columbia.

Media Advisory - Prostate Cancer Canada celebrates local Halifax hero
HALIFAX, April 25, 2012 /CNW/ - Please join Prostate Cancer Canada and members of the Halifax business community as we celebrate a local hero who has made an extraordinary contribution in the fight against prostate cancer through courage, inspiration and dedication.

Click For Information Archive
Print this page.  Bookmark this page. Decrease font size.Increase font size.


Watchful Waiting

Prostate cancer tends to be a slow growing disease and treatments do have side effects. Therefore, in some cases, it may be reasonable and safe to wait and carefully monitor the cancer’s progress before deciding to start treatment. This process is called “watchful waiting”.

In general, only men with low-stage and low-grade tumours should consider watchful waiting. You doctor may suggest treatments like surgery or radiation if your tumour starts to grow and spread. If your prostate biopsy confirms a small volume tumour (Stage 1), which is low-grade (Gleason sum 5-6), watchful waiting may be right for you.

When men with other conditions such as, severe heart or lung disease, other types of cancer, or men in their 80s or 90s, are diagnosed with prostate cancer, although treatment is technically possible, many doctors will suggest putting it off because treatments can cause more problems than the disease itself.

Watchful waiting involves regular and careful monitoring of the tumour with:

  • three monthly PSA and DRE examinations
  • regular TRUS examinations
  • repeat prostate-biopsies beginning approximately a year after diagnosis

This program of constant testing is not right for every man. The main advantage is delaying or avoiding invasive treatment and its side-effects. Canadian research suggests that watchful waiting is low risk; most men who choose to start treatment after a period of watchful waiting respond well to therapy.

To learn more about watchful waiting, watch Dr. Laurence Klotz MD, FRCSC, Professor of Surgery, University of Toronto, discuss prostate cancer, PSA levels and the benefits of watchful waiting for some patients.
 

Twitter feed temporarily unavailable.
Follow Us On Twitter
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca

Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325

Please note we cannot provide medical advice or endorse specific services, products, treatments or medical centres.
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development Inorbital